Teaching
PhD students
​
Léa Comin Since 2023 (Co-direction with Université de Paris, Sarah Zohar)
Towards a phase 0/I clinical trial platform using pharmacokinetic PET imaging to accelerate drug development
​
Cassandre Corvo since 2022, Paris-Saclay University
SV2A PET imaging to study synaptic plasticity and drug-induced synaptogenesis against psychiatric disorders
​
Amélie Soyer since 2021, Paris-Saclay University
Multimodal imaging for pharmacology and toxicology
​
Laura Rozenblum since 2021 (Co-direction with Université de Paris, Aurélie Kas)
Innovative imaging tools for brain lymphoma
​
Louise Breuil (2020-2023, Paris-Saclay University)
Exploring P-glycoprotein-mediated efflux transport at the blood-brain barrier as a biomarker of drug-resistance in focal epilepsy
Received the best Thesis Award from The Graduate School Health and Drug Sciences, Paris-Saclay University.
​
Solène Marie (2017-2020, Paris-Saclay University)
Translational imaging to study the pharmacokinetic impact of drug transporters
Received the best Thesis Award from The Graduate School Health and Drug Sciences, Paris-Saclay University.
Dominique Vodovar 2016-2018 (Co-direction with Paris Diderot, B. Mégarbane)
Imaging drug-drug interaction of interest for toxicology
​
Sylvain Auvity 2014-2017 (Co-direction with Paris Descartes, S. Cisternino).
Imaging the variability of response to opioid drugs
PharmD students
Louise Breuil (April 2020 - Paris University)
Comparing the sensitivity of PET radiotracers to detect partial inhibition of the P-glycoprotein at the blood-brain barrier
​
Sylvain Auvity (September 2017 - Paris Descartes University)
Molecular Imaging to study the neuroimmune response to opioid exposure
​
Solène Marie (July 2015 - Paris Sud University)
​Preclinical evaluation of a new PET radiologand to study the P-glycoprotein function
​
Virginie Kouyoumdjian (April 2014 - Paris Sud University)
Imaging to study the contribution of cytokines to the neuroimmune response to acute alcohol exposure.
​
Master students
Inès Arino (2024, Université Paris-Saclay)
Imaging P-gp function at the BBB of patients with drug resistant epilepsy
​
Elisa-Racky N'Diaye (2021, Université de Grenoble)
Pharmacokinetic imaging of radiolabeled nanobodies
Nora Ziani (2021, Université Rennes 1)
Imaging P-gp at the blood-brain barrier in epilepsy
​
Louise Breuil (2019 - Paris Descartes)
Comparing the sensitivity of PET radioligands to detect small changes in P-glycoprotein function at the blood-brain barrier
​
Dorra Amor (2017 - Paris Sud University)
Imaging the impact of the Solute Carrier O (SLCO)-mediated transport on the liver uptake and tissue kinetics of erlotinib in rats
​
Sébastien Goutal (2016 - Strasbourg University)
Pharmacokinetic validation of strategies to improve the brain delivery of tyrosine kinase inhibitors
​
Solène Marie (2014 - Tours University)
Imaging P-glyoprotein function at the blood-brain barrier using 11C-metoclopramide
Sylvain Auvity (2014 - Tours University)
Imaging glial activation using 18F-DPA-714 PET imaging in e rat model of morphine exposure and withdrawal
​
Sandrine Delolmo (2011 - Tours University)
Evaluation of 11C-befloxatone as a probe to study the ABCG2-mediated efflux transport at the art blood-brain barrier​
PhD defense referee
Sarah Chaib (2023, University of Lyon)
Exploration du concept pharmacologique de sélectivité fonctionnelle par l’imagerie : applications translationnelles aux récepteurs 5-HT1A »
Marie Beaurain (2022, University of Toulouse)
Étude des propriétés de ligands fluorés ciblant les récepteurs NMDA activés"
​
Matthieu Colom (2020 - University of Lyon)
Développement préclinique et clinique du [18F]F13640 pour l'imagerie des récepteurs 5-HT1A cérébraux
​
David Gomez Zepeda (2016 - Paris Descartes University)
LC-MS/MS based analysis of membrane transporters in the blood-brain barrier: interest in neuropsychopharmacology
​
Severin Maringer (2016 - Vienna University, Austria)
Radiosynthesis and Evaluation of ABC efflux transporter substrates and inhibitors
​
​
​
​
​